Follow the 리가켐바이오 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 리가켐바이오 has published 25 insider filings. The latest transaction was disclosed on 1 October 2025 (Other). Among the most active insiders: 김용주. Every trade is openly available.
25
Insider Decl.
0
Thresholds
·
16 ops.
Buy Volume
·
0 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
